CAR T-cell therapy shows promise for patients with lupus

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

For patients with systemic lupus erythematosus (SLE), chimeric antigen receptor T-cell (CAR T-cell) therapy is associated with consistent reductions in disease activity, according to research presented at the annual meeting of the American College of Rheumatology (ACR Convergence 2026), held from Nov. 6 to 11 in Orlando, Florida.

Read original article on Medical Xpress - latest medical and health news stories →